{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:26:23Z","timestamp":1791401183534,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.amjopharm.2008.10.002","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T07:14:46Z","timestamp":1227683686000},"page":"187-197","source":"Crossref","is-referenced-by-count":95,"title":["Antipsychotic drug use among elderly nursing home residents in the United States"],"prefix":"10.1016","volume":"6","author":[{"given":"Pravin","family":"Kamble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender R.","family":"Aparasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2008.10.002_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2105\/AJPH.70.5.485","article-title":"A study of antipsychotic drug use in nursing homes: Epidemiologic evidence suggesting misuse","volume":"70","author":"Ray","year":"1980","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib2","series-title":"Public Law 100-203, Title V, Subtitle C: Nursing Home Reform","article-title":"Omnibus Budget Reconciliation Act of 1987 (OBRA 87)","year":"1987"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00002512-200522040-00006","article-title":"Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: How successful have they been?","volume":"22","author":"Hughes","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1176\/ajp.149.10.1390","article-title":"The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes","volume":"149","author":"Rovner","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1532-5415.1994.tb06865.x","article-title":"Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents","volume":"42","author":"Semla","year":"1994","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.1994.03510290040034","article-title":"Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-887 regulations","volume":"271","author":"Shorr","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2105\/AJPH.85.6.771","article-title":"The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes","volume":"85","author":"Garrard","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1532-5415.1997.tb01503.x","article-title":"Effects of a restraint reduction intervention and OBRA '87 regulations on psychotropic drug use in nursing homes","volume":"45","author":"Siegler","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00005650-200012000-00003","article-title":"Influence of facility characteristics on use of antipsychotic medications in nursing homes","volume":"38","author":"Hughes","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib10","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4088\/JCP.v64n0918","article-title":"The use of atypical antipsychotics in nursing homes","volume":"64","author":"Liperoti","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.165.11.1280","article-title":"The quality of antipsychotic drug prescribing in nursing homes","volume":"165","author":"Briesacher","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1377\/hlthaff.24.1.195","article-title":"Prescription drugs and the changing patterns of treatment for mental disorders, 1996\u20132001","volume":"24","author":"Zuvekas","year":"2005","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3956(01)00020-6","article-title":"Treatment with atypical antipsychotics: New indications and new populations","volume":"35","author":"Glick","year":"2001","journal-title":"J Psychiatr Res"},{"issue":"Suppl 19","key":"10.1016\/j.amjopharm.2008.10.002_bib14","first-page":"50","article-title":"Management of the agitated elderly patients in the nursing home: The role of the atypical antipsychotics","volume":"59","author":"Verma","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 14","key":"10.1016\/j.amjopharm.2008.10.002_bib15","first-page":"49","article-title":"Antipsychotic treatment of psychosis and agitation in the elderly","volume":"61","author":"Daniel","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.38125.465579.55","article-title":"Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: Systematic review","volume":"329","author":"Lee","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib17","series-title":"Efficacy and comparative effectiveness of off-label use of atypical antipsychotics","year":"2007"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib18","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: Metaanalysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical anti-psychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib23","first-page":"11","volume":"2","author":"Koch","year":"1982","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2307\/3349613","article-title":"Societal and individual determinants of medical care utilization in the United States","volume":"51","author":"Andersen","year":"1973","journal-title":"Milbank Mem Fund Q Health Soc"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib26","first-page":"715","article-title":"Predictors of nutritional supplement use by the elderly","volume":"16","author":"Gray","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1034\/j.1600-0579.2003.00212.x","article-title":"Psychotropic prescription use by community-dwelling elderly in the United States","volume":"51","author":"Aparasu","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib28","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4088\/JCP.v66n0901","article-title":"Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics","volume":"66","author":"Liperoti","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1099-1166(200102)16:2<147::AID-GPS286>3.0.CO;2-4","article-title":"Determinants for the use of psychotropics among nursing home residents","volume":"16","author":"S\u00f8rensen","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1532-5415.2005.53403.x","article-title":"Atypical antipsychotic medications and risk of falls in residents of aged care facilities","volume":"53","author":"Hien le","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00002512-200522030-00006","article-title":"Atypical antipsychotics for nursing home patients: A retrospective chart review","volume":"22","author":"Frenchman","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archinte.167.7.676","article-title":"Variation in nursing home antipsychotic prescribing rates","volume":"167","author":"Rochon","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/gps.871","article-title":"Factors associated with antipsychotic drug use in residential care: Changes between 1990 and 1997","volume":"18","author":"Lindesay","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib34","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4088\/JCP.v67n0615","article-title":"Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia Medicaid enrollees in 2001","volume":"67","author":"Chen","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib35","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1532-5415.2007.01387.x","article-title":"Treatment of dementia in community-dwelling and institutionalized Medicare beneficiaries","volume":"55","author":"Gruber-Baldini","year":"2007","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.amjopharm.2008.10.002_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.genhosppsych.2007.08.003","article-title":"Hospital length of stay for children and adolescents diagnosed with depression: Is primary payer an influencing factor?","volume":"30","author":"Sclar","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib37","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1592\/phco.23.12.1251.32700","article-title":"Comorbidities and associated treatment charges in patients with anxiety disorders","volume":"23","author":"McLaughlin","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amjopharm.2006.03.003","article-title":"Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities","volume":"4","author":"Tour\u00e9","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1185\/030079908X260989","article-title":"Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996\u20142004","volume":"24","author":"Jano","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1543-5946(04)90015-3","article-title":"Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly","volume":"2","author":"Aparasu","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"issue":"Suppl 11","key":"10.1016\/j.amjopharm.2008.10.002_bib42","first-page":"23","article-title":"The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities","volume":"65","author":"Ballard","year":"2004","journal-title":"J Clin Psychiatr"},{"issue":"Suppl 4","key":"10.1016\/j.amjopharm.2008.10.002_bib43","doi-asserted-by":"crossref","first-page":"H7","DOI":"10.1016\/S1525-8610(04)70141-3","article-title":"Recognizing and responding to atypical antipsychotic side effects","volume":"5","author":"Jackson-Siegal","year":"2004","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib44","first-page":"1269","article-title":"Risperidone (Risperidal): Increased rate of cerebrovascular events in dementia trials","volume":"167","author":"Wooltorton","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.amjopharm.2008.10.002_bib45","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1503\/cmaj.1040539","article-title":"Olanzapine (Zyprexa): Increased incidence of cerebrovascular events in dementia trials","volume":"170","author":"Wooltorton","year":"2004","journal-title":"CMAJ"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594608000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594608000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T23:59:01Z","timestamp":1545609541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594608000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1543594608000548"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2008.10.002","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}